相关实验视频

Updated: Jun 25, 2025

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

在帕金森病的RFC1中描述复杂的重复扩展

Pilar Alvarez Jerez^1,2,3, Kensuke Daida^1,2, Abigail Miano-Burkhardt^1,2

¹Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.

NPJ Parkinson's disease

|May 24, 2024

概括

在RFC1基因的双扩张与小脑缩症,神经病变和前置体缩症综合征 (CANVAS) 有关. 这项研究在四个非芬兰欧洲帕金森病患者中发现了RFC1扩展.

科学领域:

神经遗传学神经遗传学
神经学神经学
基因组学就是基因组学.

背景情况:

在RFC1基因的AlusSx3元素中的双基 (AAGGG) 扩张是CANVAS的已知原因.
这种RFC1扩展已被确定为芬兰帕金森病 (PD) 的罕见原因.

研究的目的:

调查非芬兰欧洲帕金森病患者中RFC1 (AAGGG) 扩张的流行情况.
为了确定RFC1扩展是否是该人群中PD的显著遗传因素.

主要方法:

分析了来自帕金森氏症进展标志物倡议 (PPMI) 研究的1609名个人.
在RFC1基因中对双基 (AAGGG) 扩展进行遗传测试.

主要成果:

发现四名非芬兰裔欧洲血统的帕金森病患者携带双联RFC1 (AAGGG) 扩展.
在研究队列中的对照组中没有确定RFC1扩展的载体.

结论:

RFC1 (AAGGG) 扩展存在于非芬兰裔欧洲血统的帕金森病患者的一个子集中.
这一发现表明,RFC1扩展可能会导致芬兰人口以外的帕金森病病原体.

更多相关视频

Author Spotlight: Characterizing DNA Replication of Pathogenic Repeats to Uncover Mechanisms of Replication Fork Stalling and Expansion

Author Spotlight: Characterizing DNA Replication of Pathogenic Repeats to Uncover Mechanisms of Replication Fork Stalling and Expansion

Published on: September 13, 2024

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...